Zaynich (cefepime/zidebactam) / Wockhardt 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zaynich (cefepime/zidebactam) / Wockhardt
NCT04979806 / 2019-002768-28 / CTR20222627: Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Completed
3
530
Europe, US, RoW
Cefepime-zidebactam (FEP-ZID), Meropenem
Wockhardt, Medpace, Inc.
Complicated Urinary Tract Infection, Acute Pyelonephritis
11/24
11/24
CTR20233796: A randomized, double-blind, placebo-controlled, single-dose phase I study evaluating the pharmacokinetics, safety, and tolerability of FEP-ZID in healthy Chinese subjects.

Completed
1
12
China
1. Chinese Generic Name: Cefepime-zidebactam; English Generic Name: Cefepime-zidebactam; Brand Name: NA; 2. Chinese Generic Name: Placebo (0.9% Sodium Chloride Injection); English Generic Name: Placebo (Natrium Chloride 0.9%); Brand Name: Ecoflac Plus ? 100ml
Wockhardt Bio AG / Fuqirui Pharmaceutical R&D (Beijing) Co., Ltd. / ACS Dobfar SpA
Indications: For the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis (AP).
 
 
NCT06806995: A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.

Completed
1
30
US
Zidebactam-Cefepime, Metronidazole, FEP-ZID
Wockhardt, Eric Solutions LLC
PHA1A
02/25
02/25

Download Options